发明申请
- 专利标题： Acyl Hydrazines as Kinase Inhibitors, in Particular for Sgk
- 专利标题（中）： 酰基肼作为激酶抑制剂，特别是Sgk
-
申请号： US11910673申请日： 2006-03-10
-
公开(公告)号： US20080167380A1公开(公告)日： 2008-07-10
- 发明人: Rolf Gericke , Dieter Dorsch , Werner Mederski , Markus Klein , Norbert Beier , Florian Lang
- 申请人： Rolf Gericke , Dieter Dorsch , Werner Mederski , Markus Klein , Norbert Beier , Florian Lang
- 优先权： DE102005015255.4 20050404
- 国际申请： PCT/EP2006/002220 WO 20060310
- 主分类号： A61K31/275
- IPC分类号： A61K31/275
摘要：
Novel acyl hydrazides of the formula (I), in which R1-R9 have the meanings indicated in claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and complaints, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, generally in fibroses and inflammatory processes of any type.
公开/授权文献
- US07767716B2 Acyl hydrazines as kinase inhibitors, in particular for SGK 公开/授权日：2010-08-03
信息查询
